Previous Article | Next Article ![]()
Infect Immun, July 1998, p. 3128-3133, Vol. 66, No. 7
Department of Cell Biology,
Received 6 February 1998/Returned for modification 24 March
1998/Accepted 15 April 1998
Entry of Listeria monocytogenes into nonphagocytic
cells requires the inlAB gene products. InlA and InlB are
bacterial cell wall-associated polypeptides that can be released by
sodium dodecyl sulfate treatment. By applying more gentle extraction
methods, we have purified InlB in its native form. Treatment of
bacteria with various nondenaturating agents including mutanolysin,
thiol reagents, sodium chloride, and detergents like Triton X-100 or 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate did not
release substantial amounts of InlB from the bacterial cell wall.
Instead, InlB was nearly quantitatively extracted in a solubilized form
by treatment of bacteria with 1 M Tris-Cl or other protonated amines at
pH 7.5. However, the reduced solubility of the extracted InlB in
low-salt buffers hampered further biochemical purification. A panel of
monoclonal antibodies against listerial Tris-Cl extracts containing
InlB was therefore produced to generate reagents for use in affinity
chromatography. One of the monoclonal antibodies enabled purification
of the InlB protein to homogeneity with relatively high yields. When
added externally, purified InlB associated with the surface of
noninvasive bacteria such as Listeria innocua or an
L. monocytogenes inlB2 mutant, where it promoted entry of
these strains into Vero cells >300- and 17-fold, respectively. This effect was even more dramatic for HeLa cells, where the observed invasion was increased about 9,000- and 4,000-fold, respectively. The
availability of purified native, invasion-competent InlB will allow
analysis of the molecular basis of InlB-mediated entry into tissue
culture cell lines in greater detail.
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Purification of the inlB Gene Product of
Listeria monocytogenes and Demonstration of Its
Biological Activity

*
Corresponding author. Mailing address: Gesellschaft
für Biotechnologische Forschung, Abteilung Zellbiologie,
Mascheroder Weg 1, D-38124 Braunschweig, Germany. Phone:
49-531-6181-415. Fax: 49-531-6181-444. E-mail: jwe{at}gbf.de.
Present address: Department of Molecular Microbiology, Washington
University Medical School, St. Louis, MO 63110.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|